Biotechnology

First successful trans-femoral mitral valve repair device DragonFly™ performed in China

HANGZHOU, China, July 29, 2020 /PRNewswire/ -- On July 23, 2020, Professor Jian'an Wang's team at the Second Affiliated Hospital of Zhejiang University School of Medicine successfully completed the world's first human clinical application of the transcatheter mitral valve repair system (Dragon...

2020-07-29 23:00 2568

Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets

SHANGHAI and NEWYORK, July 28, 2020 /PRNewswire/ -- Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generatingde novo crystal structures of high-value targets. Under the terms ...

2020-07-29 07:00 11131

Sherpa Healthcare Partners Announces Close of Oversubscribed Fund

BEIJING, July 27, 2020 /PRNewswire/ -- Sherpa Healthcare Partners is pleased to announce the final closing of the oversubscribed Sherpa Healthcare Fund I, L.P. The fund focuses on early- to growth-stage investment in the healthcare sector to cover companies in biotech, biopharma, medical devices ...

2020-07-28 11:33 2457

K-BioMed Pioneer: VUNO Med®-Fundus AI™ Becomes Korea's First-ever Innovative Medical Device

SEOUL, South Korea, July 27, 2020 /PRNewswire/ -- VUNO Inc., South Korean artificial intelligence (AI) developer and a member company of theBorn2Global Centre, announced that VUNO Med®-Fundus AI™, its AI-based screening solution for the fundus, gained the honor of being the first-ever Innovative ...

2020-07-27 22:00 2531

Happiness Biotech Announces Financial Results for Fiscal Year Ended March 31, 2020

NANPING, China, July 24, 2020  /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its financial results for the fiscal year endedMarch 31, 2020. FY 2020 Financial Highlights: ...

2020-07-25 05:00 24537

Gracell Expands Executive Team by Appointment of CMO Dr. Martina Sersch and CFO Dr. Kevin Xie

SHANGHAI and SUZHOU, China, July 23, 2020 /PRNewswire/ -- Internationally renowned clinical-stage immune cell and gene therapy company, Gracell Biotechnologies Co., Ltd. ("Gracell" or "the Company") has announced two appointments to the executive suite. Chief Medical Officer Dr.Martina Sersch, M...

2020-07-23 22:00 2684

Singlera Genomics and Fudan University unveiled results demonstrating detection of five common cancers earlier than standard test

SAN DIEGO and SHANGHAI, July 21, 2020 /PRNewswire/ -- Fudan University's Taizhou Health Science Institute and Singlera Genomics, focused on non-invasive early cancer detection, today announce the publication of a peer reviewed manuscript demonstrating the initial results from the Taizhou Longitud...

2020-07-21 23:00 1966

GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and ...

2020-07-21 22:04 2661

Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today strong financial results for its fiscal 2020 second quarter endingJune 30, 2020, maintaining steady business performance with a high operating margin at 26.4%.

2020-07-21 20:20 16774

PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit

GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European...

2020-07-20 21:00 1999

Bridge Biotherapeutics becomes BaseLaunch's first Asia Pacific partner

SEONGNAM, South Korea and BASEL, Switzerland, July 14, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc.(KOSDAQ: 288330), a clinical stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunch, theBasel Area -based biotech venture accelerator and incubator, today announces tha...

2020-07-15 07:00 14438

Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology

Shanghai, July 13, 2020 /PRNewswire/ -- Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its$32mn Series A financing led by Morningside Ventures, together with its existing investors. Arctic V...

2020-07-14 09:30 3046

NTHU Research Team Develops a Rapid Test Kit for Potential Severe Covid-19 Cases

HSINCHU, July 13, 2020 /PRNewswire/ -- Professor Cheng Chao-Min of the Institute of Biomedical Engineering at National Tsing Hua University has recently developed a new covid-19 rapid test kit which allows the physician to provide timely treatment to high-risk patients, thereby making more effici...

2020-07-14 01:00 1275

Samsung Biologics signs additional development and manufacturing agreement with STCube

SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM418, an anti-PD1 immuno-oncology candidate. STM418 received much attention from the biopha...

2020-07-12 08:00 1786

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary w...

2020-07-09 16:32 1600

ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

DAEJEON, South Korea, July 7, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO). A patent...

2020-07-08 01:00 1348

A Breakthrough in Cancer Treatment: Soundny Presents a New Drug-based Alternative in Fight Against Cancer

WUHAN, China, July 7, 2020 /PRNewswire/ -- Hubei Soundny Biotechnology ("Soundny" or the "Company"), a leading biotechnology company dedicated to developing cancer treatments, has announced the publication of its latest findings on cholangiocarcinoma in Nature Biomedical Engineering, a Nature pu...

2020-07-07 13:25 1089

New strategic partnership to develop next-generation T cell detection reagents

SHANGHAI, China and COPENHAGEN, Denmark, July 2, 2020 /PRNewswire/ -- Today two MedTech companies, Polaris Biology ofChina and Tetramer Shop of Denmark, announce a strategic partnership to co-develop and distribute technologies that accelerate T cell science. First on the agenda is to commerciali...

2020-07-02 21:00 1310

Transcenta Announces First Patient Dosed in Phase I Clinical Trial of Claudin18.2 Targeting Monoclonal Antibody TST001 in the US

SUZHOU, China, July 1, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successfull...

2020-07-01 23:00 1080

Hitachi and ThinkCyte announce collaboration to develop an AI-driven cell analysis and sorting system

TOKYO, July 1, 2020 /PRNewswire/ -- Hitachi, Ltd. (TSE: 6501, "Hitachi") and ThinkCyte, Inc. ("ThinkCyte") today announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system. Hitachi provides a broad range of s...

2020-07-01 22:00 6438
1 ... 119120121122123124125 ... 129